Table 2.

Active protein biomarker discovery and validation trials involving urine analysis; via clinicaltrials.gov.

Conditions	Enrollment	Identifier	Urine focus
Female Stress Urinary Incontinence	40	NCT02023502	+
IgA Nephropathy	200	NCT01879514	+
Diabetic Nephropathy, Retinopathy	3500	NCT02040441	+
Acute Kidney Injury in Sepsis Patients	150	NCT01981993	+
Ischemic Brain Injury, Stroke	750	NCT00983723	−
Chronic Kidney Disease (CKDu)	350	NCT02226055	−
Colorect., Esophag., Gastric, Panc. Cancer	1000	NCT00899626	−
Lung Cancer	2000	NCT00898313	−
Heart Transplantation	482	NCT00042614	−
Duchenne Muscular Dystrophy (DMD)	220	NCT01380964	−
Lung Transplant Rejection	60	NCT00558597	−
Kidney Transplant Infection	1000	NCT01515605	−
Urinary Incontinence	10	NCT01987336	−
Hyperoxia	40	NCT02553668	−

Note: Many studies include urine orthogonally with serum, CSF, or tissue samples for biomarker discovery and are shown as (−) under “urine focus” where urine analysis provides complementary information. Those primarily analyzing urine for biomarkers are shown as (+) under “urine focus”.